Global Patent Index - EP 1017808 A2

EP 1017808 A2 20000712 - 53BP2 COMPLEXES

Title (en)

53BP2 COMPLEXES

Title (de)

53BP2-KOMPLEXE

Title (fr)

COMPLEXES DE 53BP2

Publication

EP 1017808 A2 20000712 (EN)

Application

EP 98946136 A 19980922

Priority

  • US 9819791 W 19980922
  • US 93545097 A 19970923

Abstract (en)

[origin: WO9915657A2] The present invention discloses complexes of the 53BP2 protein with proteins identified as interacting with 53BP2 (53BP2-IPs) by a yeast two hybrid assay system. The proteins which were demonstrated to interact with 53BP2 are: beta -tubulin, p62, hnRNP G, and three gene products, 53BP2:IP-1, 53BP2:IP-2 and 53BP2:IP-3, which are encoded (in part) by the EST R72810 sequence. Thus, the present invention discloses complexes of 53BP2 and beta -tubulin, p62, hnRNP G, 53BP2:IP-1, 53BP2:IP-2 and 53BP2:IP-3, and derivatives, fragments and analogs thereof. The present invention also discloses the 53BP2:IP-1, 53BP2:IP-2 and 53BP2:IP-3 genes and proteins, as well as derivatives, fragments and analogs thereof. Methodologies for screening the aforementioned complexes for efficacy in treating and/or preventing certain diseases and disorders (particularly, cancer, autoimmune disease and neurodegenerative disease) are also provided by the present invention.

IPC 1-7

C12N 15/12; C12N 15/62; C12N 1/19; C07K 14/47; C07K 14/18; C12Q 1/00; C12Q 1/68; G01N 33/68; G01N 33/566; A61K 38/17; A61K 39/395; A01K 67/027

IPC 8 full level

A01K 67/027 (2006.01); A61K 38/00 (2006.01); A61K 39/395 (2006.01); A61K 48/00 (2006.01); A61P 13/08 (2006.01); A61P 17/02 (2006.01); A61P 17/06 (2006.01); A61P 25/28 (2006.01); A61P 35/00 (2006.01); A61P 37/06 (2006.01); C07K 14/18 (2006.01); C07K 14/47 (2006.01); C07K 16/08 (2006.01); C12N 1/19 (2006.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12N 15/85 (2006.01); C12Q 1/00 (2006.01); C12Q 1/68 (2006.01); G01N 33/15 (2006.01); G01N 33/50 (2006.01); G01N 33/566 (2006.01); G01N 33/68 (2006.01)

CPC (source: EP US)

A61P 13/08 (2017.12 - EP); A61P 17/02 (2017.12 - EP); A61P 17/06 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 37/06 (2017.12 - EP); C07K 14/47 (2013.01 - EP US); C12N 15/8509 (2013.01 - EP US); A01K 2207/15 (2013.01 - EP US); A01K 2217/00 (2013.01 - EP US); A01K 2217/05 (2013.01 - EP US); A01K 2217/075 (2013.01 - EP US); A01K 2267/03 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US); A61K 48/00 (2013.01 - EP US); C07K 2319/00 (2013.01 - EP US)

Citation (search report)

See references of WO 9915657A2

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

DOCDB simple family (publication)

WO 9915657 A2 19990401; WO 9915657 A3 19990916; AU 9321898 A 19990412; CA 2303405 A1 19990401; EP 1017808 A2 20000712; JP 2001517439 A 20011009; US 5977311 A 19991102; US 6627405 B1 20030930

DOCDB simple family (application)

US 9819791 W 19980922; AU 9321898 A 19980922; CA 2303405 A 19980922; EP 98946136 A 19980922; JP 2000512949 A 19980922; US 33812399 A 19990622; US 93545097 A 19970923